Laboratory Centrifuge Market

Laboratory Centrifuge Market Research, 2032

The global laboratory centrifuge market size was valued at $1.9 billion in 2022, and is projected to reach $2.9 billion by 2032, growing at a CAGR of 4.1% from 2023 to 2032. The growth of the laboratory centrifuge market size is driven by an increase in R&D activities by using laboratory centrifuge technique and rise in awareness regarding diagnosis of diseases in developing nations. In addition, the rise in prevalence of chronic and infectious diseases increases the demand for laboratory centrifuge for diagnosis of these diseases and drives the growth of laboratory centrifuge market share. For instance, according to the Joint United Nations Program on HIV and AIDS (UNAIDS), 39 million [33.1 million–45.7 million] people globally were living with HIV in 2022. Hence, all such factors boost the growth of the market.

The development of innovative technologies or the improvement of existing laboratory centrifuge have experienced delays during recession. This delay could slow down the ability of the market to introduce more efficient, accurate, and user-friendly laboratory centrifuge, which hinder market growth.

Key Takeaways:

• On the basis of product, the equipment segment was the highest contributor to the market in 2022.
• On the basis of the model, the benchtop centrifuges segment dominated the market in 2022.
• On the basis of the rotor design, the fixed angle rotors segment dominated the market in 2022.
• On the basis of application, the diagnostic segment was the highest contributor to the market in 2022.
• On the basis of end user, the hospitals & clinical laboratories segment was the highest contributor to the market in 2022.
• On the basis of region, Asia-Pacific is expected to witness the highest CAGR during the laboratory centrifuge market forecast period.

A laboratory centrifuge is a widely used equipment in the laboratory for separating components based on their different densities by application of centripetal acceleration. Laboratory centrifuge has wide application in microbiology, cellomics, proteomics, genomics, blood component separation, and diagnostics.

Market Dynamics

Centrifuge is used in separation of plasma from blood and the plasma derivatives are used in manufacturing therapeutic protein drugs, which are essential medicines in the treatment of liver diseases and others. Thus, the rise in prevalence of liver diseases increases the demand of blood components and propels the growth of laboratory centrifuge market share, globally. For instance, according to the World Gastroenterology Organization, global prevalence of liver cirrhosis is 4.5 to 9.5% of the total general population. According to article “Global burden of liver disease: 2023 update” of Journal Hepatology, published in March 2023, liver disease accounts for over two million deaths annually (cirrhosis, viral hepatitis, and liver cancer) and accounts for 4% of all deaths worldwide (1 out of every 25 deaths); 1 out of 3 liver-related deaths occur among females. Within this estimate, liver cancer accounts for 600,000 to 900,000 deaths.

Furthermore, centrifuges are employed to concentrate and separate blood cells for counting and analysis, aiding in the diagnosis of blood disorders, anemia, and leukemia. Thus, the rise in blood disorder is expected to drive the growth of laboratory centrifuge market. For instance, according to the Leukemia Foundation, more than 110,000 people were living with blood cancer or a related blood disorder in Australia in 2021. More than 18,485 Australians were expected to be newly diagnosed with blood cancer, such as leukemia, lymphoma, and myeloma every year.

However, the high cost of laboratory centrifuge & accessories is the major factor that restrains the global laboratory centrifuges market. On the contrary, a rise in R&D activities in genomics, proteomics and cellomics, and rise in number of academic & research institutes which use laboratory centrifuges are expected to drive the growth of market.

In addition, the rise in launch of technological advanced laboratory centrifuge provides a lucrative opportunity for the growth of the laboratory centrifuge market during the forecast period. New product launches often incorporate the latest technological innovations, such as miniaturization and portability, improved speed and acceleration, enhanced cooling systems, and integration with automation and robotics. For instance, in April 2021, Kubota Corporation launched Benchtop Centrifuge Model S500T and Floor Standing Refrigerated Centrifuge Model S500FR. These models have innovative and safe control features such as "Self-Check Function", "Imbalance Early Detector", "Mixed-loading buckets", and "3-year warranty”.

Recession 2023 Impact Analysis on Laboratory Centrifuge Market

In the healthcare industry, recession results in reduced funding for R&D activities, including laboratory centrifuge. However, the intrinsic value of laboratory centrifuge equipment & accessories in providing comprehensive and efficient healthcare information suggests that the long-term potential of the market remains promising.  The demand for advanced laboratory centrifuge products that offer a holistic perspective on the health of a patient is anticipated to propel the laboratory centrifuge market back onto a growth trajectory.

Moreover, the healthcare industry, including pharmaceutical and biotechnology companies, typically demonstrates some level of delay in technological advancement, as the technological progress often relies on sustained research investments, which are disrupted during recessions. Ultimately, the specific impact of a recession on the laboratory centrifuge market in 2023 would depend on a range of factors, including the severity and duration of the recession, government policies, industry trends, and individual company strategies. 

Furthermore, rise in prevalence of disease, increase in R&D activities, surge in launch of laboratory centrifuge, and high growth potential in developing countries are expected to drive the market growth rate during the forecast period.

Segmental Overview

The laboratory centrifuge market is segmented on the basis of product, model, rotor design, application, end user, and region. On the basis of the product, the market is divided into equipment and accessories. The equipment segment is further divided into microcentrifuges, multipurpose centrifuges, minicentrifuges, and ultracentrifuges. The accessories segment is further segregated into rotors, tubes, centrifuge bottles, plates, centrifuge buckets, and others.As per model, the market is classified into benchtop centrifuges and floor-standing centrifuges. On the basis of rotor design, the market is divided into swinging bucket rotors, fixed angle rotors, and vertical rotors.

According to application, the laboratory centrifuge market is segregated into diagnostic, microbiology, cellomics, proteomics, genomics, blood component separation, and others. Depending on the end user, the market is segregated into hospitals & clinical laboratories, biotechnology & pharmaceutical companies, academic & research institutes. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

By Product

The equipment segment dominated the market in 2022, owing to high adoption of laboratory centrifuge equipment and high cost of laboratory centrifuge equipment. However, the accessories segment is expected to witness the highest CAGR during the forecast period, owing to a rise in recurring purchase of accessories for increasing research and diagnostic applications and increase in R&D labs which further uses accessories.

By Model 

The benchtop centrifuges segment generated maximum revenue in 2022, owing to high adoption of benchtop centrifuges and wider availability of benchtop centrifuges. The same is expected to witness the highest CAGR during the forecast period, owing to offers various advantages such as suitable for smaller laboratories with limited space and highly recommendation for benchtop centrifuges from lab technician.

By Rotor Design

The fixed angle rotors segment generated maximum revenue in 2022, owing to high adoption of fixed-angle rotors and advantages of fixed-angle rotors are that they have a more compact design and suitable for high-speed applications in smaller centrifuges. The swinging bucket rotors segment is expected to witness the highest CAGR during the forecast period, owing to rise in technological advancement in swinging bucket rotors and various advantages such as the swinging motion of the buckets helps to distribute the sample evenly along the sides of the tubes, resulting in more uniform pelleting.

By Application
The diagnostic segment generated maximum revenue in 2022, owing to wide applications of laboratory centrifuge in diagnostic and high use for diagnosis of diseases. The blood component separation segment is expected to witness the highest CAGR during the forecast period, owing to a rise in use of laboratory centrifuge in blood component separation and increase in demand of blood component.

By End User
The hospitals & clinical laboratories segment generated maximum revenue in 2022, owing to increase in awareness regarding diagnosis of diseases and highly adoption of laboratory centrifuge by hospitals & clinical laboratories. The academic & research institutes segment is expected to witness the highest CAGR during the forecast period, owing to rise in number of academic & research institutes which further uses laboratory centrifuge and rise in R&D activities in which laboratory centrifuge used.

By Region

North America accounted for a major share of the laboratory centrifuge market in 2022 and is expected to maintain its dominance during the forecast period. The presence of several major players, such as Agilent Technologies Inc. (California), Becton, Dickinson and Company (New Jersey), Danaher Corporation (Washington), and Thermo Fisher Scientific Inc. (Massachusetts), and high healthcare expenditure from government organizations in the region drive the growth of the market. Moreover, the high adoption rate of laboratory centrifuge and the significant increase in capital income in developed countries boost the growth of the laboratory centrifuge market in North America.

Furthermore, the availability of advanced research laboratories, and availability of newly launched products in the region fosters the growth of the market. In addition, the U.S. is anticipated to contribute to a major share of the regional market and is expected to drive the growth of the laboratory centrifuge market during the forecast period. The presence of key players, R&D labs, high medical tourism, and high purchasing power propels the growth of the market.

Asia-Pacific is expected to grow at the highest rate during the forecast period, owing to rise in the number of people suffering from chronic and infectious disease, increase in awareness regarding the diagnosis of infectious diseases such as HIV and hepatitis, and surge in purchasing power of populated countries, such as China and India. Furthermore, the market growth in the region is attributable to factors such as entry of key players, increase in per capita spending, and increase in government initiatives for improving healthcare infrastructure. The countries in Asia-Pacific possess a huge population base, with China being the first having 1,411,778,724 population in 2020 and India as the second most populated country having 1,380,004,385 population in 2020. Therefore, a rise in population along with longer life expectancy is expected to drive the laboratory centrifuge market growth in Asia-Pacific during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the laboratory centrifuge market, such as Agilent Technologies Inc., Becton, Dickinson and Company, Danaher Corporation, Eppendorf SE, Kubota Corporation, Lepu Medical Technology (Beijing) Co., Ltd., NuAire, QIAGEN N.V., Sartorius AG, and Thermo Fisher Scientific Inc., are provided in the report. These major players have adopted acquisition and product launch as key developmental strategies to improve their product portfolio. 

Recent Acquisition in the Laboratory Centrifuge Industry

In March 2020, Eppendorf AG and Koki Holdings Co., Ltd., have reached an agreement that Eppendorf will acquire Koki’s centrifuge business, including the premium himac brand. A corresponding agreement was signed by both companies in Tokyo. The acquisition marks a targeted step by Hamburg-based Eppendorf AG to expand its centrifuge business and solidifies its strong market position as one of the world’s leading makers of high-end centrifuges for the pharma and life science industries as well as academic and commercial research.

Recent Product Launch in the Laboratory Centrifuge Industry    

In September 2022, Thermo Fisher Scientific Inc., a U.S. (Massachusetts) based company, unveiled the Thermo Scientific DynaSpin Single-Use Centrifuge system at the BioProcess International annual conference in Boston, MA. The system is specifically designed to provide an optimal single-use solution for large-scale cell culture harvesting. The DynaSpin system improves and streamlines harvesting for cell culture separation in single-use bioprocesses by reducing the number of depth filtration cartridges required to complete the harvest process.

In April 2021, Eppendorf introduced a new centrifuge designed to increase efficiency in the laboratory, Centrifuge 5910 Ri. With the introduction of Centrifuge 5910 Ri, Eppendorf now offers scientists advanced features to simplify and accelerate the centrifugation steps of their workflow. An innovative touchscreen interface allows for quick setting of desired parameters while three levels of user management and new documentation options provide enhanced security and traceability.

In April 2021, Kubota Corporation launched Benchtop Centrifuge Model S500T and Floor Standing Refrigerated Centrifuge Model S500FR. These models have new innovation and safe control features such as "Self-Check Function", "Imbalance Early Detector", "Mixed-loading buckets", and “3-year warranty”.

In October 2020, Eppendorf introduced the refrigerated 24-place centrifuge 5425 R, the successor of its popular centrifuge 5424 R. The new device comes with a bundle of improvements, making applications in the field of molecular and cell biology easier than ever. The variety of 6 different rotors now covers even more applications, including molecular biology applications such as DNA/RNA or protein separations in 1.5-2.0mL vessels or spin columns, harvesting of bacteria, yeast, and cell cultures in 5 mL tubes, as well as micro-volume protocols, such as pre/post PCR and qPCR set ups in 0.2 ml tubes, strips, or divisible 96-well plates.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the laboratory centrifuge market analysis from 2022 to 2032 to identify the prevailing laboratory centrifuge market opportunity.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the laboratory centrifuge market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global laboratory centrifuge market trends, key players, market segments, application areas, and market growth strategies.

 Laboratory Centrifuge Market Report Highlights